Table 1.
Demographic characteristics of the study population according to RRI
| RRI |
pa | ||
|---|---|---|---|
| <70 (n = 134) | ≥70 (n = 155) | ||
| Age, years | 59.43±11.15 | 67.71±10.13 | 0.001b, ** |
| Female sex | 91 (46.9%) | 103 (53.1%) | 0.792a |
| Body mass index, kg/m2 | 30.49±5.77 | 30.25±6.10 | 0.733b |
| Smoking | 25 (39.7%) | 38 (60.3%) | 0.229a |
| Chronic obstructive lung disease | 10 (47.6%) | 11 (52.4%) | 0.905 |
| Hyperlipidemia | 42 (43.8%) | 54 (56.2%) | 0.529 |
| Statins | 21 (39.6%) | 32 (60.4%) | 0.276 |
| Coronary artery disease | 33 (45.2%) | 40 (54.8%) | 0.818 |
| Cerebrovascular accident | 4 (28.6%) | 10 (71.4%) | 0.171 |
| ACE inhibitors | 91 (43.5%) | 118 (56.5%) | 0.119 |
| Calcium channel blockers | 38 (44.7%) | 47 (55.3%) | 0.715 |
| Beta-blockers | 32 (45.1%) | 39 (54.9%) | 0.801 |
| Acetylsalicylic acid | 45 (38.8%) | 71 (61.2%) | 0.035* |
| LV hypertrophy | 24 (28.9%) | 59 (71.1%) | 0.001** |
| Normal geometry | 27 (58.7%) | 19 (41.3%) | 0.067 |
| Concentric remodeling | 74 (56.9%) | 56 (43.1%) | 0.001** |
| Concentric hypertrophy | 27 (33.8%) | 53 (66.2%) | 0.008** |
| Eccentric hypertrophy | 6 (18.2%) | 27 (81.8%) | 0.001** |
Values are presented as mean ± standard deviation or n (%). ACE, angiotensin-converting enzyme; LV, left ventricular; RRI, renal resistive index.
a
Pearson's χ2 test.
b
Student's t test.
*
p < 0.05
**
p < 0.01.